Lista de obras - Anna Watson - Dominio Público Uruguay

A Novel Interaction Between Sympathetic Overactivity and Aberrant Regulation of Renin by miR-181a in BPH/2J Genetically Hypertensive Mice

artículo científico publicado en 2013

Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice

artículo científico publicado en 2012

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

artículo científico publicado en 2009

Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade

artículo científico publicado en 2005

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis

artículo científico publicado en 2009

Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure

artículo científico publicado en 2012

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.

artículo científico publicado en 2010

Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species

artículo científico publicado en 2019

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta ⬇️

artículo científico publicado en 2010

Effect of central urotensin II on heart rate, blood pressure and brain Fos immunoreactivity in conscious rats

scientific journal article

Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex

artículo científico publicado en 2007

Leptin-target neurones of the rat hypothalamus express somatostatin receptors

artículo científico publicado en 2003

Linking RAGE and Nox in diabetic micro- and macrovascular complications

artículo científico publicado en 2015

Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

artículo científico publicado en 2018

Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.

artículo científico publicado en 2014

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

artículo científico publicado en 2008

Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep

artículo científico publicado en 2008

SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus

artículo científico publicado en 2019

Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep

artículo científico publicado en 2004

The AGE/RAGE axis in diabetes-accelerated atherosclerosis.

artículo científico publicado en 2008

The emerging role of NADPH oxidase NOX5 in vascular disease

artículo científico publicado en 2017

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

artículo científico publicado en 2009

The endothelin system and endothelin receptor antagonists

artículo científico

The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat.

artículo científico publicado en 2002

The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy

artículo científico publicado en 2017

Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions

artículo científico publicado en 2003

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

artículo científico publicado en 2013

Urotensin II, a novel peptide in central and peripheral cardiovascular control

artículo científico publicado en 2004

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression ⬇️

artículo científico publicado en 2010

Lista de obras de Anna Watson

A Novel Interaction Between Sympathetic Overactivity and Aberrant Regulation of Renin by miR-181a in BPH/2J Genetically Hypertensive Mice

Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis

Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.

Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta ⬇️

Effect of central urotensin II on heart rate, blood pressure and brain Fos immunoreactivity in conscious rats

Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex

Leptin-target neurones of the rat hypothalamus express somatostatin receptors

Linking RAGE and Nox in diabetic micro- and macrovascular complications

Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep

SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus

Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep

The AGE/RAGE axis in diabetes-accelerated atherosclerosis.

The emerging role of NADPH oxidase NOX5 in vascular disease

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

The endothelin system and endothelin receptor antagonists

The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat.

The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy

Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

Urotensin II, a novel peptide in central and peripheral cardiovascular control

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression ⬇️